Friday, August 12, 2022
HomeLatest NewsCovid-19Joint CDC and FDA Statement on J&J Covid Vaccine

Joint CDC and FDA Statement on J&J Covid Vaccine

U.S. Department of Health & Human Services (HHS) released a joint statement from the Centers of Disease Control (CDC) and Federal Drug Administration (FDA) on the Johnson & Johnson COVID-19 Vaccine. Based on six reported cases of a rare and severe type of blood clot, HHS recommends that vaccine providers pause on administering the Johnson & Johnson (J&J) COVID-19 vaccine.

The CDC’s Advisory Committee on Immunization Practices (ACIP) is meeting April 14 and will provide updates. The CDC and FDA will provide additional information and answer questions at a media briefing. A recording of that media call will be available on the FDA’s YouTube channel.

People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider. Health care providers are asked to report adverse events to the Vaccine Adverse Event Reporting System.

Stay Connected

Unified Voice Newsletter

Events This Month

august

16aug12:00 pm1:00 pmLeading a Change-Ready, Inclusive EnvironmentSDAHO Webinar Series12:00 pm - 1:00 pm CST Event Type :Education Events,Webinar

18aug12:00 pm1:00 pmMastering Difficult Conversations with Compassionate ConfidenceSDAHO Webinar12:00 pm - 1:00 pm CST Event Type :Education Events,Webinar

23aug11:00 am12:00 pmThe Role of Guardianship & Conservatorship in Improving Patient OutcomesSDAHO Webinar11:00 am - 12:00 pm CST Event Type :Education Events,Webinar

24aug1:00 pm2:00 pmKey 2022 Health Care Trends, the Current State of Skilled Nursing/Long-Term Care and Using Data to Gain ClarityPartner Education1:00 pm - 2:00 pm CST Event Type :Education Events,Webinar

25aug11:00 am12:00 pmFilling Gaps In Physician Network Practice ManagementMHA Webinar11:00 am - 12:00 pm CST Event Type :Education Events,Webinar

X


By submitting this form, you are consenting to receive marketing emails from: SDAHO, 3708 W Brooks Place, Sioux Falls, SD, 57106, http://sdaho.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact